2018 / 02

Next Paper
DOI: 10.24075/brsmu.2018.025
Copyright: © 2018 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Changes in the sensitivity of human glioblastoma cells to oncolytic enteroviruses induced by passaging

Soboleva AV1,2, Lipatova AV1, Kochetkov DV1, Chumakov PM2
About authors

1 Engelhardt Institute of Molecular Biology, Moscow

2 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow

Correspondence should be addressed: Peter M. Chumakov
ul. Vavilova 32, Moscow, 119991; moc.oohay@mpvokamuhc

About paper

Funding: this work was supported by the Ministry of Education and Science of the Russian Federation (Project ID RFMEFI60714X0014).

Received: 2018-06-16 Accepted: 2018-07-22 Published online: 2018-07-08
|
  1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008; 359 (5): 492–507.
  2. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006; 24 (16): 2563–2569. DOI: 10.1200/ JCO.2005.04.5963. PubMed PMID: 16735709.
  3. Sosnovtceva AO, Grinenko NF, Lipatova AV, Chumakov PM, Chekhonin VP. Onkoliticheskie virusy v terapii zlokachestvennih gliom. Biomeditsinskaia khimiia. 2016; 62 (4): 376–90. DOI: 10.18097/pbmc20166204376. PubMed PMID: 27562991.
  4. Gubanova NV, Gaytan AS, Razumov IA, Mordvinov VA, Krivoshapkin AL, Netesov SV, et al. Onkoliticheskie virusy v terapii gliom. Molecular Biology. 2012; 46 (6): 726–38.
  5. Csatary LK, Bakacs T. Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma. JAMA. 1999; 281 (17): 588–589.
  6. Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 2000; 7 (10): 867–874.
  7. Csatary LK, Gosztonyi G, Szeberenyi J, Fabian Z, Liszka V, Bodey B, et al. MTH-68/H oncolytic viral treatment in human high- grade gliomas. J Neurooncol. 2004; 67 (1–2): 83–93.
  8. Iwadate Y, Inoue M, Saegusa T, Tokusumi Y, Kinoh H, Hasegawa M, et al. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats. Clin Cancer Res. 2005; 11 (10): 3821–27.
  9. Allen C, Opyrchal M, Aderca I, Schroeder MA, Sarkaria JN, Domingo E, et al. Oncolytic measles virus strains have significant antitumor activity against glioma stem cells. Gene Ther. 2012; 23 (10): 62.
  10. Alonso MM, Jiang H, Gomez-Manzano C, Fueyo J. Targeting brain tumor stem cells with oncolytic adenoviruses. Methods Mol Biol. 2012; 797: 111–125.
  11. Dey M, Ulasov IV, Lesniak MS. Virotherapy against malignant glioma stem cells. Cancer Lett. 2010; 289 (1): 1–10.
  12. Kanai R, Rabkin SD, Yip S, Sgubin D, Zaupa CM, Hirose Y, et al. Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. J Natl Cancer Inst. 2012; 104 (1): 42–55.
  13. van den Hengel SK, Balvers RK, Dautzenberg IJ, van den Wollenberg DJ, Kloezeman JJ, Lamfers ML, et al. Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures. Cancer Gene Ther. 2013; 20(9): 507–513. DOI: 10.1038/ cgt.2013.47. PubMed PMID: 23907517.
  14. Zhu Z, Gorman MJ, McKenzie LD, Chai JN, Hubert CG, Prager BC, et al. Zika virus has oncolytic activity against glioblastoma stem cells. J Exp Med. 2017; 214 (10): 2843–57. DOI: 10.1084/ jem.20171093. PubMed PMID: 28874392; PubMed Central PMCID: PMCPMC5626408.
  15. Voroshilova MK. Potential use of nonpathogenic enteroviruses for control of human disease. Prog Med Virol. 1989; 36: 191–202. PubMed PMID: 2555836.